Reducing the demand for magnetic resonance imaging scans and prostate biopsies during the early detection of clinically significant prostate cancer: Applying the Barcelona risk-stratified pathway in Catalonia

CONCLUSION: The application of the BCN-RSP would reduce the demand for mpMRI scans and prostate biopsies by one fifth while less than 5% of csCaP would remain undetected. The overdetection of insignificant CaP would decrease by more than one quarter and the performance of prostate biopsy for csCaP detection would increase to higher than 40%.PMID:38342654 | DOI:10.1016/j.urolonc.2023.09.020

Source: Urologic Oncology - February 11, 2024 Category: Urology & Nephrology Authors: Juan Morote Ángel Borque-Fernando Luis E Esteban Nat àlia Picola Jes ús Muñoz-Rodriguez Nahuel Paesano Xavier Ruiz-Plazas Marta V Mu ñoz-Rivero Anna Celma Gemma Garc ía-de Manuel Berta Mir ó Jos é M Abascal Pol Servian Source Type: research